The present invention relates to a nucleic acid encoding a polypeptide and
the use of the nucleic acid or polypeptide in preventing and/or treating
cancer. In particular, the invention relates to improved vectors for the
insertion and expression of foreign genes encoding tumor antigens for use
in immunotherapeutic treatment of cancer.